R.PR
REGISTERED-PRINCIPAL REGISTER
04/03/2025
Voltar para busca
Dado oficial do USPTO
PEPTIDREAM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
PEPTIDREAM
ST13
US500000097933982Classe
1, 5, 35, 40, 42
Pedido
97933982
Registro
7709589
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
04/03/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 35, 40, 42
Data de depósito
12/05/2023
Data de registro
04/03/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
04/03/2025
Última transação
04/03/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
03
Localização do titular
Kawasaki-Shi, Kanagawa, JP
Examinador
DAWE III, BILL
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
PeptiDream Inc.
Representantes
Harris A. Wolin MYERS WOLIN, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 35Classe 40Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for the manufacture of pharmaceuticals; synthesized peptides for scientific and research use; Reagents for biological and chemical purposes and for research purposesexcluding those for medical or veterinary use; Proteins and synthesized peptides used in the research and the development and manufacture of pharmaceuticals and biologicals; Chemical reagents used for the detectionmeasurement and identification of genetic materials or compoundsexcluding those for medical and veterinary use
Classe 5
Synthesized peptides used in drug discovery of various pharmaceuticals for the treatment of various to different diseases and medical conditions; Chemical preparations used in drug discovery for the treatment of various diseases and medical conditions and for pharmaceutical purposes; Central nervous system drugspharmaceutical preparations for the treatment of various diseases and medical conditions affecting the central nervous system; Peripheral nerve drugspharmaceutical agents for the treatment of various diseases and medical conditions affecting the peripheral nervous system; Drugs affecting sensory organspharmaceutical agents for the treatment of various diseases and medical conditions affecting sensory organs; Antiallergic drugspharmaceutical antiallergic preparations and substances; Cardiovascular drugscardiovascular pharmaceutical preparations; Drugs affecting respiratory organspharmaceutical preparations for treating respiratory diseases; Drugs affecting digestive organspharmaceutical preparations for the treatment of various diseases and medical conditions affecting digestive organs; Drugs for outer skinpharmaceutical preparations for the treatment of various diseases and medical conditions for skin care; Pharmaceutical preparations for the treatment of various diseases and medical conditions of Metabolic disorders; Cellular function activating drugs for the treatment of various diseases and medical conditions for medical purposes; Pharmaceutical preparations for the treatment of various diseases and medical conditions for suppressing tumors; diagnostic preparations for medical purposes; Pharmaceutical preparations using synthesized peptides used in drug discovery and pharmaceuticals for the treatment of various diseases and medical conditions for medical purposes; Synthesized proteins and chemical preparations used in drug discovery and pharmaceuticals for the treatment of various diseases and medical conditions for medical purposes
Classe 35
Retail and wholesale store services featuring chemicals; Retail and wholesale store services featuring pharmaceuticals and medical supplements
Classe 40
Manufacture of synthetic peptides to the order and specification of others; Peptide synthesis for othersmanufacture of synthetic peptides to the order and specification of others; Manufacture of pharmaceuticals and chemicals to the order and specification of others; Manufacture of synthetic proteins to the order and specification of others; Amino acid synthesis for othersmanufacture of amino acids to the order and specification of others
Classe 42
Testingexaminationinspection and research services in the field of pharmaceuticalscosmeticsfoodsthe provision of information or advice thereto; Testingexaminationinspection and research services in the field of medical organisms or bacteriathe provision of information or advice thereto; Testingexaminationinspection and research services in the field of chemistrythe provision of information or advice thereto; Testingexaminationinspection and research services in the field of medical carethe provision of information or advice thereto; Testingexaminationinspection and research services in the field of biotechnologythe provision of information or advice thereto; Testingexaminationinspection and research services in the field of the identification of hit lead peptidesthe provision of information or advice thereto; Testingexaminationinspection and research services in the field of the identification of hit-lead compoundsthe provision of information or advice thereto; Testingexaminationinspection and research services in the field of the analysis and synthesis of peptidesthe provision of information or advice thereto; Testingexaminationinspection and research services in the field of the analysis and synthesis of proteinsthe provision of information or advice thereto; The generation of a library of peptides and the provision of information or advice thereto; Testingexaminationinspection and research services in the fields of pharmaceuticalscosmeticsfoodsmedical organisms or bacteriachemistrymedical carebiotechnologyidentification of hit lead peptidesanalysis and synthesis of peptidesusing automated screening machines and the provision of information or advice thereto; Scientific research in the nature of conduction of clinical trials for others; Quality control of peptides used in drug development; Advice on quality control of peptides used in drug development
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/03/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/01/2025
PUBO
PUBLISHED FOR OPPOSITION
14/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/01/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/12/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
17/12/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17/12/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
17/12/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
17/12/2024
DMCC
DATA MODIFICATION COMPLETED
13/12/2024
ALIE
ASSIGNED TO LIE
13/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/12/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/12/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
24/09/2024
GNRT
NON-FINAL ACTION E-MAILED
24/09/2024
CNRT
NON-FINAL ACTION WRITTEN
24/09/2024
ALIE
ASSIGNED TO LIE
19/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/05/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/02/2024
GNRT
NON-FINAL ACTION E-MAILED
08/02/2024
CNRT
NON-FINAL ACTION WRITTEN
08/02/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/02/2024
GNRT
NON-FINAL ACTION E-MAILED
07/02/2024
CNRT
NON-FINAL ACTION WRITTEN
07/02/2024
DOCK
ASSIGNED TO EXAMINER
06/02/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/06/2023
NWAP
NEW APPLICATION ENTERED
16/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PEPTIDREAM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.